Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Extrawell Pharmaceutical Holdings Current Ratio?
Extrawell Pharmaceutical HoldingsHKSE:00858 -1.19% Current Ratio is 6.04 as of Mar. 2026, which is 84% above its 10-year median of 3.29. The stock has 5 warning signs investors should review. Among 998 Drug Manufacturers companies, Extrawell Pharmaceutical Holdings ranks better than 89.18% on this metric.
Extrawell Pharmaceutical Holdings has a current ratio of 6.04. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Extrawell Pharmaceutical Holdings's Current Ratio or its related term are showing as below:
HKSE:00858'
s Current Ratio Range Over the Past 10 Years
Min: 2.1 Med: 3.29 Max: 21.91
Current: 6.04
During the past 13 years, Extrawell Pharmaceutical Holdings's highest Current Ratio was 21.91. The lowest was 2.10. And the median was 3.29.
HKSE:00858's Current Ratio is ranked better than 89.18% of 998
companies
in the Drug Manufacturers industry
Industry Median: 1.92
vs HKSE:00858: 6.04
Extrawell Pharmaceutical Holdings (HKSE:00858) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Extrawell Pharmaceutical Holdings Current Ratio Related Terms
Extrawell Pharmaceutical Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Extrawell Pharmaceutical Holdings Current Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Extrawell Pharmaceutical Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extrawell Pharmaceutical Holdings Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Extrawell Pharmaceutical Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Extrawell Pharmaceutical Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Extrawell Pharmaceutical Holdings (HKSE:00858) has a Current Ratio of 6.04 as of Mar. 2026. This is 84% above median its historical median of 3.29. Over the past decade, Extrawell Pharmaceutical Holdings' Current Ratio has ranged from 2.10 to 21.91. According to the industry distribution chart, Extrawell Pharmaceutical Holdings ranks #108 out of 998 companies in the Drug Manufacturers industry, placing it in the top 10.8%.
Is Extrawell Pharmaceutical Holdings' Current Ratio too high?
Extrawell Pharmaceutical Holdings' current Current Ratio of 6.04 is 84% above median its 10-year median of 3.29. Over the past 10 years, this metric has ranged from a low of 2.10 to a high of 21.91. The Drug Manufacturers industry median Current Ratio is 1.92. Extrawell Pharmaceutical Holdings' value of 6.04 is 214.6% above this industry median. Based on the distribution chart, Extrawell Pharmaceutical Holdings ranks #108 out of 998 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Extrawell Pharmaceutical Holdings' Current Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Extrawell Pharmaceutical Holdings ranks #108 out of 998 companies for Current Ratio. This places Extrawell Pharmaceutical Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.92. Extrawell Pharmaceutical Holdings' value of 6.04 is 214.6% above this benchmark. Historically, Extrawell Pharmaceutical Holdings' own Current Ratio has ranged from 2.10 to 21.91 over the past decade. While the company's 10-year median is 3.29 vs. the industry median of 1.92, Extrawell Pharmaceutical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 1.92, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Extrawell Pharmaceutical Holdings's current Current Ratio of 6.04 is 214.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Extrawell Pharmaceutical Holdings's current Current Ratio is 6.04, which is 84% above median its own 10-year median of 3.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extrawell Pharmaceutical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Extrawell Pharmaceutical Holdings (HKSE:00858) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.08 — trading 66% above its estimated fair value. The current Current Ratio is 6.04, which is 84% above median its 10-year median of 3.29 and 214.6% above the Drug Manufacturers industry median of 1.92. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Extrawell Pharmaceutical Holdings (HKSE:00858), the current Current Ratio is 6.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing, Trading, and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Geographically, it derives a majority of its revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00858 has been successfully added to your 
